Elon Musk's brain-implant company Neuralink on Thursday, May 25, said it had received the approval of the US Food and Drug Administration (FDA) to launch a first-in-human clinical study. Several times since 2019, billionaire Elon Musk has predicted his brain-chip company would soon secure FDA approval for human trials. But the company's application was rejected in early 2022, and the company was working through the agency's concerns over the safety of the experimental implant. READ: Elon Musk says Neuralink will put chips in human brains within 6 months "This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an importan...Keep on reading: Elon Musk’s Neuralink gets US FDA approval for human clinical study of brain implants